Anaptysbio Stock Price on December 9, 2024
| ANAB Stock | USD 14.55 0.45 3.00% |
Below is the normalized historical share price chart for AnaptysBio extending back to January 26, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of AnaptysBio stands at 14.55, as last reported on the 20th of December, with the highest price reaching 15.29 and the lowest price hitting 14.20 during the day.
If you're considering investing in AnaptysBio Stock, it is important to understand the factors that can impact its price. AnaptysBio secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of standard deviation over the last 3 months. AnaptysBio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AnaptysBio's mean deviation of 4.26, and Risk Adjusted Performance of (0.13) to double-check the risk estimate we provide.
At present, AnaptysBio's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 30.2 K, whereas Total Stockholder Equity is forecasted to decline to about 83.7 M. . As of December 20, 2024, Price To Sales Ratio is expected to decline to 31.93. In addition to that, Price Earnings Ratio is expected to decline to -3.7. AnaptysBio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of January 2017 | 200 Day MA 27.4603 | 50 Day MA 24.7098 | Beta (0.24) |
AnaptysBio |
Sharpe Ratio = -0.1637
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ANAB |
Estimated Market Risk
| 6.85 actual daily | 60 60% of assets are less volatile |
Expected Return
| -1.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AnaptysBio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AnaptysBio by adding AnaptysBio to a well-diversified portfolio.
Price Book 5.4101 | Enterprise Value Ebitda (1.30) | Price Sales 7.9835 | Shares Float 19.9 M | Wall Street Target Price 35.7 |
Related Headline
Crinetics Pharmaceuticals Headline on 9th of December 2024
Crinetics Announces FDA Acceptance of New Drug Application f... by finance.yahoo.com
FDA Assigns a Prescription Drug User Fee Act Target Action Date of September 25, 2025SAN DIEGO, Dec. 09, 2024 -- Crinetics Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration accepted its New Drug Application for investigational candidate paltusotine for the treatment and long-term maintenance therapy of acromegaly in adults. If approved, paltusotine will be the first and only once-daily, oral, selective somatostatin receptor ty
AnaptysBio Valuation on December 9, 2024
It is possible to determine the worth of AnaptysBio on a given historical date. On December 9, 2024 AnaptysBio was worth 24.86 at the beginning of the trading date compared to the closed value of 22.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AnaptysBio stock. Still, in general, we apply an absolute valuation method to find AnaptysBio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AnaptysBio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AnaptysBio's related companies.
| Open | High | Low | Close | Volume | |
| 23.80 | 24.95 | 23.67 | 24.81 | 660,214 | |
12/09/2024 | 24.86 | 25.88 | 22.77 | 22.88 | 505,200 |
| 23.25 | 23.40 | 22.16 | 23.09 | 365,028 |
| Backtest AnaptysBio | | | AnaptysBio History | | | AnaptysBio Valuation | Previous | Next |
AnaptysBio Trading Date Momentum on December 9, 2024
| On December 10 2024 AnaptysBio was traded for 23.09 at the closing time. The top price for the day was 23.40 and the lowest listed price was 22.16 . The trading volume for the day was 365 K. The trading history from December 10, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.92% . The overall trading delta against the current closing price is 33.78% . |
AnaptysBio Fundamentals Correlations and Trends
By evaluating AnaptysBio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AnaptysBio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AnaptysBio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About AnaptysBio Stock history
AnaptysBio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AnaptysBio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AnaptysBio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AnaptysBio stock prices may prove useful in developing a viable investing in AnaptysBio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.9 M | 21 M | |
| Net Loss | -115.9 M | -110.1 M |
AnaptysBio Quarterly Net Working Capital |
|
AnaptysBio Stock Technical Analysis
AnaptysBio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
AnaptysBio Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
AnaptysBio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
AnaptysBio December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how AnaptysBio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AnaptysBio shares will generate the highest return on investment. By undertsting and applying AnaptysBio stock market strength indicators, traders can identify AnaptysBio entry and exit signals to maximize returns
AnaptysBio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AnaptysBio's price direction in advance. Along with the technical and fundamental analysis of AnaptysBio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AnaptysBio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.24) | |||
| Total Risk Alpha | (1.36) | |||
| Treynor Ratio | (0.38) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |